Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aloris Vital is a Slovakian pharmaceutical company founded in 2014 that specializes in the development and commercialization of innovative medical devices, nutritional supplements, and dermo-cosmetics. The company is best known for its Vizalor brand, particularly the Vizalor AB-Protears eye drops, which utilize a unique postbiotic formulation containing Lactobacillus sakei lysate to stabilize the tear film and modulate ocular inflammation. Aloris Vital operates across several therapeutic areas, including ophthalmology, urology, immunology, and dermatology, providing both proprietary products and acting as a strategic partner for international manufacturers entering the Central European market. With a focus on evidence-based solutions, the company has established a significant presence in Slovakia and the Czech Republic through partnerships with distributors like Valtix Pharma.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vizalor.